CX Institutional lifted its stake in shares of Genpact Limited (NYSE:G – Free Report) by 102.7% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 361,074 shares of the business services provider’s stock after buying an additional 182,960 shares during the period. CX Institutional’s holdings in Genpact were worth $11,746,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. WINTON GROUP Ltd grew its holdings in Genpact by 178.8% in the second quarter. WINTON GROUP Ltd now owns 48,666 shares of the business services provider’s stock worth $1,338,000 after purchasing an additional 31,213 shares during the period. Tidal Investments LLC raised its stake in Genpact by 135.5% during the 2nd quarter. Tidal Investments LLC now owns 57,011 shares of the business services provider’s stock worth $1,568,000 after buying an additional 32,805 shares during the period. Engineers Gate Manager LP grew its stake in Genpact by 42.9% in the second quarter. Engineers Gate Manager LP now owns 224,729 shares of the business services provider’s stock valued at $6,180,000 after acquiring an additional 67,482 shares during the period. Edgestream Partners L.P. increased its holdings in shares of Genpact by 862.8% during the first quarter. Edgestream Partners L.P. now owns 114,167 shares of the business services provider’s stock valued at $4,253,000 after acquiring an additional 102,309 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Genpact in the 2nd quarter worth $1,452,000. Institutional investors and hedge funds own 96.03% of the company’s stock.
Genpact Stock Performance
NYSE:G traded down $1.40 during trading on Friday, reaching $33.30. The company’s stock had a trading volume of 1,814,398 shares, compared to its average volume of 2,458,524. Genpact Limited has a 12 month low of $26.85 and a 12 month high of $48.64. The firm has a market cap of $5.60 billion, a price-to-earnings ratio of 9.88, a price-to-earnings-growth ratio of 0.87 and a beta of 0.57. The firm has a 50 day moving average of $35.22 and a 200-day moving average of $33.72. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.00 and a current ratio of 2.00.
Genpact Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, September 10th were given a dividend of $0.1875 per share. The ex-dividend date was Thursday, September 10th. This represents a $0.75 annualized dividend and a dividend yield of 2.3%. Genpact’s dividend payout ratio is currently 22.26%.
Insider Buying and Selling at Genpact
In related news, SVP Anil Nanduru sold 6,191 shares of the stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total transaction of $229,252.73. Following the sale, the senior vice president owned 70,253 shares of the company’s stock, valued at approximately $2,601,468.59. This represents a 8.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.58% of the company’s stock.
Analysts Set New Price Targets
G has been the topic of several research reports. Deutsche Bank Aktiengesellschaft set a $31.00 price objective on shares of Genpact in a report on Friday, July 10th. Needham & Company LLC lowered their target price on shares of Genpact from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Friday, August 7th. Citigroup lifted their price target on Genpact from $32.00 to $36.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Robert W. Baird dropped their target price on Genpact from $45.00 to $38.00 and set a “neutral” rating on the stock in a report on Tuesday, July 7th. Finally, JPMorgan Chase & Co. lifted their target price on Genpact from $40.00 to $45.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $39.33.
Get Our Latest Stock Report on Genpact
About Genpact
Genpact Ltd. (NYSE:G) is a global professional services and technology company that helps organizations transform business processes and operations. Its services combine consulting, digital technology, data and artificial intelligence, and domain expertise to support process modernization, automation, and operational improvement.
The company provides services across finance and accounting, procurement, supply chain management, customer experience, risk and compliance, lending, and analytics.
Featured Stories
- Five stocks we like better than Genpact
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
